Cambridge Healthtech Institute’s 15th Annual

Diagnostics Innovation

At-Home, Point-of-Care, and Direct Access Testing

May 4-5, 2026

The Diagnostics Innovation program of the 33rd Annual Tri-Con will bring together healthcare leaders, investors, executives, entrepreneurs, and innovators to explore the latest technologies and opportunities shaping the future of diagnostics, including at-home and point-of-care technologies, direct access testing, and infectious disease diagnostics, cancer diagnostics and liquid biopsy, and emerging women’s health testing. The program will also examine reimbursement and market access models.

Coverage will include, but is not limited to:

• At-home and point-of-care diagnostics
• Direct access testing
• Infectious disease diagnostics
• Liquid biopsy and multi-cancer early detection
• Market access for advanced diagnostics
• Women’s health diagnostics

The deadline for priority consideration is November 21, 2025.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation:

• To submit a podium presentation, please click here.

   

• To become a sponsor, click here.

   

• To sign up to attend, click here.

For more details on the conference, please contact:

Julia Boguslavsky

Executive Director, Conferences

Cambridge Healthtech Institute

Email: juliab@healthtech.com

For sponsorship information, please contact: